ArticleScientific reports2024

JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans.

Anne M Fourie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.